Development of antibody response to SARS‐CoV‐2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy. (29th July 2021) - Chan, Wei Yee; Sanchez, Emilie; Chavda, Selina J.; Lecat, Catherine S. Y.; Ainley, Louise; Xu, Ke; Wisniowski, Brendan; Mahmood, Shameem; Papanikolaou, Xenofon; Kyriakou, Charalampia; Sive, Jonathan; Wechalekar, Ashutosh; et al.